Renaissance Capital logo

Ambit Biosciences Priced, Nasdaq: AMBI.XX

Developing small molecule therapeutics for the treatment of acute myeloid leukemia.

Industry: Health Care

First Day Return: -7.6%

Industry: Health Care

Developing small molecule therapeutics for the treatment of acute myeloid leukemia.
more less
IPO Data
IPO File Date 02/20/2013
Offer Price $8.00
Price Range $8.00 - $8.00
Offer Shares (mm) 8.1
Deal Size ($mm) $65
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 05/15/2013
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $65
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters San Diego, CA, United States
Founded 2000
Employees at IPO 45
Website www.ambitbio.com

Ambit Biosciences (AMBI.XX) Performance